Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wu, Xinyu ^a   Li, Yirong ^a   Wang, Jinhua ^a   Wen, Xin ^a   Marcus, Max T ^a   Daniels, Garrett ^a   Zhang, David Y ^b   Ye, Fei ^b   Wang, Ling Hang ^a   Du, Xinxin ^a   Adams, Sylvia ^a   Singh, Baljit ^a   Zavadil, Jiri ^a   Lee, Peng ^a,c   Monaco, Marie E ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; ENZYME; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ETOPOSIDE; LAPATINIB; LONG CHAIN FATTY ACYL COA SYNTHETASE 4; MESSENGER RNA; STEROID HORMONE; STEROID RECEPTOR; TAMOXIFEN; TRIACSIN C; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DATA BASE; DRUG SENSITIVITY; GENE EXPRESSION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUDE MOUSE; QUADRUPLE NEGATIVE BREAST CANCER; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; COENZYME A LIGASES; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84885395288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077060     Document Type: Article

References (54)

1. Curigliano G, Goldhirsch A, (2011) The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer. JNCI Monogr, 2011(2011): 108-110 PubMed: 22043054.
2. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, et al. (2005) Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24: 4660-4671. doi:10.1038/sj.onc.1208561. PubMed: 15897907.
3. Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, et al. (2008) Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 13: 431-435. doi:10.1007/s10147-008-0770-6. PubMed: 18946753.
4. Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, et al. (2011) Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer. Cancer Cell 20: 119-131. doi:10.1016/j.ccr.2011.05.026. PubMed: 21741601.
5. Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ, et al. (2011) Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol 22: 1288-1294. doi:10.1093/annonc/mdq586. PubMed: 21109569.
6. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, et al. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121: 2750-2767. doi:10.1172/JCI45014. PubMed: 21633166.
7. Monaco ME, Creighton CJ, Lee P, Zou X, Topham MK, et al. (2010) Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity. Transl Oncol 3: 91-98. PubMed: 20360933.
8. Lewin TMK, Granger: J-H., D.A.; Vance JE, Coleman RA (2001) Acyl-CoA synthetase isoforms. p. pp. 1, are present in different subcellular membranes in rat liver and can be inhibited independently. Journal of Biological Chemistry 276: 24674-24679.
9. Van Horn CG, Caviglia JM, Li LO, Wang S, Granger DA, et al. (2005) Characterization of Recombinant Long-Chain Rat Acyl-CoA Synthetase Isoforms 3 and 6: Identification of a Novel Variant of Isoform 6. Biochemistry 44: 1635-1642. doi:10.1021/bi047721l. PubMed: 15683247.
10. Liang YC, Wu CH, Chu JS, Wang CK, Hung LF, et al. (2005) Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase. World J_Gastroenterol 11: 2557-2563. PubMed: 15849811.
11. Cao Y, Dave KB, Doan TP, Prescott SM, (2001) Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res 61: 8429-8434. PubMed: 11731423.
12. Maloberti PM, Duarte AB, Orlando UD, Pasqualini ME, Solano ÅR, et al. (2010) Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells. PLOS ONE 5: e15540. doi:10.1371/journal.pone.0015540. PubMed: 21085606.
13. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM, (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc_Natl_Acad_Sci_U_S_A 97: 11280-11285. PubMed: 11005842.
14. Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, et al. (2008) Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Oncogene 27: 3201-3210. doi:10.1038/sj.onc.1210983. PubMed: 18193092.
15. Hosohata K, Li P, Hosohata Y, Qin J, Roeder RG, et al. (2003) Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription. Mol Cell Biol 23: 7019-7029. doi:10.1128/MCB.23.19.7019-7029.2003. PubMed: 12972618.
16. Wang D, Ye F, Sun Y, Li W, Liu H, et al. (2011) Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Am J Pathol 179: 1657-1666. doi:10.1016/j.ajpath.2011.06.010. PubMed: 21854745.
17. Wang H, Gillis A, Zhao C, Lee E, Wu J, et al. (2011) Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells. Mutat Res 723: 171-176. doi:10.1016/j.mrgentox.2011.04.008. PubMed: 21570478.
18. Ye F, Che Y, McMillen E, Gorski J, Brodman D, et al. (2009) The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer 61: 530-537. doi:10.1080/01635580902803719. PubMed: 19838925.
19. Zhang DY, Ye F, Gao L, Liu X, Zhao X, et al.; Zhang DY, Ye F, Gao L, Liu X, Zhao X, Che Y, Wang H, Wang L, Wu J, Song D, Liu W, Xu H, Jiang B, Zhang W, Wang J, Lee P, (2009) Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div: 4. PubMed: 19863813: 20. PubMed: 19863813.
20. Taneja S, MacGregor J, Markus S, Ha S, Mohr I, (2001) Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells. Proc Natl Acad Sci USA 98: 8804-8808. doi:10.1073/pnas.161011798. PubMed: 11438715.
21. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527. doi:10.1016/j.ccr.2006.10.008. PubMed: 17157791.
22. Hoeflich KP, O'Brien C, Boyd Z, Cavet G, Guerrero S, et al. (2009) In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models. Clin Cancer Res 15: 4649-4664. doi:10.1158/1078-0432.CCR-09-0317. PubMed: 19567590.
23. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, et al. (2006) Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer. J Clin Oncol 24: 4236-4244. doi:10.1200/JCO.2006.05.6861. PubMed: 16896004.
24. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Oncomine: A cancer microarray database and integrated data-mining platformNeoplasia 6: 1-6.
25. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679. doi:10.1016/S0140-6736(05)17947-1. PubMed: 15721472.
26. Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, et al. (2010) Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat 123: 661-677. doi:10.1007/s10549-009-0653-1. PubMed: 19960244.
27. Ma X-J, Dahiya S, Richardson E, Erlander M, Sgroi DC, (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11: R7. doi:10.1186/bcr2268. PubMed: 19187537.
28. Anderson E, Clarke RB, (2004) Steroid Receptors and Cell Cycle in Normal Mammary Epithelium. J Mammary Gland Biol Neoplasia 9: 3-13. doi:10.1023/B:JOMG.0000023584.01750.16. PubMed: 15082914.
29. Prat A, Adamo B, Cheang MCU, Anders CK, Carey LA, et al. (2013) Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer. Oncologist 18: 123-133. doi:10.1634/theoncologist.2012-0397. PubMed: 23404817.
30. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68. doi:10.1186/bcr2635. PubMed: 20813035.
31. Al Saleh S, Al Mulla F, Luqmani YA, (2011) Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells. PLOS ONE 6: e20610. doi:10.1371/journal.pone.0020610. PubMed: 21713035.
32. Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, et al. (2009) Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Cancer Sci 100: 1556-1562. doi:10.1111/j.1349-7006.2009.01203.x. PubMed: 19459852.
33. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, et al. (2012) Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries. Cell 149: 525-537. doi:10.1016/j.cell.2012.03.028. PubMed: 22521361.
34. Meloni I, Muscettola M, Raynaud M, Longo I, Bruttini M, et al. (2002) FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat_Genet 30: 436-440. PubMed: 11889465.
35. Kantojärvi K, Kotala I, Rehnström K, Ylisaukko-oja T, Vanhala R, et al. (2011) Fine mapping of Xq11.1-q21.33 and mutation screening of RPS6KA6, ZNF711, ACSL4, DLG3, and IL1RAPL2 for autism spectrum disorders (ASD). Autism Res 4: 228-233. doi:10.1002/aur.187. PubMed: 21384559.
36. Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, et al. (2004) Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25: 641-649. PubMed: 15289865.
37. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE, (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11: R32. doi:10.1186/bcr2402. PubMed: 19473496.
38. Osborne CK, Schiff R, (2011) Mechanisms of Endocrine Resistance in Breast Cancer. Annu Rev Med 62: 233-47. PubMed: 20887199.
39. Gajria D, Chandarlapaty S, (2011) HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies. Expert Rev Anticancer Ther 11: 263-275. doi:10.1586/era.10.226. PubMed: 21342044.
40. Doane AS, Danso M, Lal P, Donaton M, Zhang L, et al. (2006) An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25: 3994-4008. doi:10.1038/sj.onc.1209415. PubMed: 16491124.
41. Emad A, Rakha MEE-S, Green Andrew R, Lee Andrew HS, Robertson John F, Ellis Ian O (2007) Prognostic markers in triple-negative breast cancer. Cancer 109: 25-32. doi:10.1002/cncr.22381. PubMed: 17146782.
42. Gucalp A, Traina TA, (2010) Triple-negative breast cancer: role of the androgen receptor. Cancer J 16: 62-65. doi:10.1097/PPO.0b013e3181ce4ae1. PubMed: 20164692.
43. He J, Peng R, Yuan Z, Wang S, Peng J, et al. (2011) Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Med Oncol, 28: 1-5. PubMed: 20041315.
44. Luo X, Shi Y-X, Li Z-M, Jiang W-Q, (2010) Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer 29: 585-590. doi:10.5732/cjc.009.10673. PubMed: 20507730.
45. Grigoriadis A, Mackay A, Noel E, Wu PJ, Natrajan R, et al. (2012) Molecular characterisation of cell line models for triple-negative breast cancers. BMC Genomics 13: 619. doi:10.1186/1471-2164-13-619. PubMed: 23151021.
46. Creighton CJ, Fu X, Hennessy BT, Casa AJ, Zhang Y, et al. (2010) Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer. Breast Cancer Res 12: R40. doi:10.1186/bcr2693. PubMed: 20569503.
47. Orlando UD, Garona J, Ripoll GV, Maloberti PM, Solano AR, et al. (2012) The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target. PLOS ONE 7: e40794. doi:10.1371/journal.pone.0040794. PubMed: 22808264.
48. Mashima T, Sato S, Sugimoto Y, Tsuruo T, Seimiya H, (2008) Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions. Oncogene 28: 9-19. PubMed: 18806831.
49. Oksenberg N, Stevison L, Wall JD, Ahituv N, (2013) Function and Regulation of AUTS2, a Gene Implicated in Autism and Human Evolution. PLOS Genet 9: e1003221.
50. Sirchia SM, Tabano S, Monti L, Recalcati MP, Gariboldi M, et al. (2009) Misbehaviour of XIST RNA in Breast Cancer Cells. PLOS ONE 4: e5559. doi:10.1371/journal.pone.0005559. PubMed: 19440381.
51. Black PN, Faergeman NJ, DiRusso CC, (2000) Long-Chain Acyl-CoA-Dependent Regulation of Gene Expression in Bacteria, Yeast and Mammals. J Nutr 130: 305-. PubMed: 10721893.
52. Golej DL, Askari B, Kramer F, Barnhart S, Vivekanandan-Giri A, et al. (2011) Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells. J Lipid Res 52: 782-793. doi:10.1194/jlr.M013292. PubMed: 21242590.
53. Hughes-Fulford M, Li C-F, Boonyaratanakornkit J, Sayyah S, (2006) Arachidonic Acid Activates Phosphatidylinositol 3-Kinase Signaling and Induces Gene Expression in Prostate Cancer. Cancer Res 66: 1427-1433. doi:10.1158/0008-5472.CAN-05-0914. PubMed: 16452198.
54. Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, et al. (2010) Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease. Obes Surg 20: 640-650. doi:10.1007/s11695-010-0078-2. PubMed: 20119733.